In the study of the correlation between USP22 and acquired cisplatin resistance in lung adenocarcinoma, the expression of USP22 was found to be upregulated in cisplatin-resistant lung adenocarcinoma cells (56). This evidence concerns the gene USP22 and lung adenocarcinoma.